Photobiomodulation Effects on Blood Pressure and Vascular Function in Treated Hypertensive Patients

This double-blind, randomized, sham-controlled clinical trial aims to evaluate the effects of vascular photobiomodulation on blood pressure and vascular function in hypertensive patients treated with losartan. A total of 80 patients using losartan (100 mg/day for at least two months) will be recruited and followed for 4 weeks. Participants will be randomly allocated to either an active photobiomodulation group or a sham control group.

NCT Number	NCT07525310
Lead Sponsor	University of Nove de Julho
Conditions	Hypertension
Enrollment	80 participants
Start Date	2026-05-01
Primary Completion	2027-08-31 (estimated)
Study Completion	2027-11-30 (estimated)
Updated on ClinicalTrials.gov	2026-04-13